Just for the sake of argument let's say that was true. Why was the futility of it unanticipated? Why undertake the expense of a Phase 2 under those circumstances?
"The problem was that Daptomycin went generic. Brilacidin would have been competing against a "good enough" generic drug resulting in little revenue.